Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

NCT02933879 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: NVXT topical
DRUG: Placebo (Vehicle) Topical

Sponsor

Sun Pharmaceutical Industries, Inc.